The increased expression of HPSE2, SYND1, MMP9, and TIMP2 observed in psoriasis patients, even when psoriatic plaques are not present, suggests their involvement in primary changes associated with psoriasis and their potential as candidate proteins for targeted treatments to reverse ECM modifications (Wagner et al., 2021). Here, HPSE2 is linked to psoriasis.